Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 2 1Phase 1 1

Status

Active not recruiting 4Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Lymphoma, Follicular 2Lung Neoplasms 2Hematologic Neoplasms 2Colonic Neoplasms 2Carcinoma, Neuroendocrine 2Breast Neoplasms 2Thyroid Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myocarditis 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Liver Metastases 1Liver Malignancy 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Intraabdominal Infections 1Head and Neck Neoplasms 1

Interventions

enzalutamide 94Magnetic Resonance Spectroscopy 86Specimen Handling 66Prednisone 66Androgen Antagonists 60Abiraterone Acetate 58apalutamide 56Radiosurgery 53darolutamide 48Radiotherapy 47Leuprolide 47abiraterone 46Docetaxel 43Pluvicto 32Radiation 31acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30Biopsy 30Surveys and Questionnaires 29relugolix 28pembrolizumab 26gallium 68 PSMA-11 26Standard of Care 26Triptorelin Pamoate 25Goserelin 25bicalutamide 23Gonadotropin-Releasing Hormone 23Brachytherapy 21Carboplatin 20cabazitaxel 19X-Rays 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Positron Emission Tomography Computed Tomography × 1 year × Clear all
NCT05683964 2026-02-13

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Active not recruiting
9 enrolled
Genitourinary

Prostatic Neoplasms

NCT06062745 2025-11-05

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Brigham and Women's Hospital

Phase 1 Recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT06479187 2025-11-05

PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

Brigham and Women's Hospital

Phase 4 Active not recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT04030338 2025-09-03

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Memorial Sloan Kettering Cancer Center

Active not recruiting
58 enrolled
Genitourinary

Prostatic Neoplasms

NCT03204123 2025-07-09

PSMA PET Imaging of Recurrent Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
1,171 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡